Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS | More
Noel Doheny, CEO of Epigenomics, spoke with me during Tomorrow Can’t Wait, the 2017 Colorectal Cancer Alliance conference. Epigenomics has developed the first FDA and PMA approved liquid biopsy test to screen for colorectal cancer.
Please like & share: